Can semaglutide be used to treat alcohol use disorder?
The Lancet’s Niall Boyce and Jonathan Pimm, and eBioMedicine’s Kalypso Karastergiou discuss an exciting new potential treatment for alcohol use disorder: semaglutide. As new research is published in The Lancet, they go behind the headlines with lead author Professor Anders Fink-Jensen to ask what the study showed, and what its implications are for the future of addiction medicine. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Lancet in conversation with
Louise Chappell and Na’ama Carlin on Personal Cancer Stories
Susannah Stanway on the London Global Cancer Week
Carlos Monteiro, Camila Corvalán, and Phil Baker on Ultra-Processed Foods and Human Health
Presented at ASH: the EPCORE FL-1 study on epcoritamab in follicular lymphoma
Get summaries like this every morning.
Free AI-powered recaps of The Lancet in conversation with and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.